{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:00:14Z","timestamp":1794535214348,"version":"4.9.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Emergence of malignant ureteral obstruction (MUO) has been reported as a sign of poor prognosis; however, the distribution of survival time in patients with MUO is considerably wide, and no risk classification score has been constructed. To evaluate whether a novel risk classification score for overall survival that we previously developed, is effective in a large cohort. Investigator-initiated, prospective, multicenter diagnostic\/prognostic study was conducted. Patients with MUO were divided into three risk groups based on the score calculated using four prognostic factors (PLaCT: Primary site, Laterality, serum Creatinine level, and Treatment for primary site) at the first visit, and prospective follow-up was performed. Overall survival and ureteral stent failure-free survival of each risk group were compared. In total, 300 patients with 21 different primary sites were enrolled. The numbers of patients in good, intermediate, and poor risk groups were 105, 106, and 89, respectively. Median survival times of patients in good, intermediate, and poor risk groups were 406, 221, and 77\u00a0days, respectively (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001). In 217 patients with ureteral stenting, median ureteral stent failure-free survival times of good, intermediate, and poor risk groups were 385, 183, and 57\u00a0days, respectively (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001). Limitations include the limited ethnicity and the extended duration of study enrollment. The novel PLaCT risk classification score could divide MUO patients into three risk groups with distinct survival times and ureteral stent patencies. This score will aid in establishing prognosis and treatment strategy for all physicians engaged in cancer treatment.<\/jats:p>","DOI":"10.1038\/s41598-021-84054-7","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T11:03:35Z","timestamp":1614164615000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["A novel risk classification score for malignant ureteral obstruction: a multicenter prospective validation study"],"prefix":"10.1038","volume":"11","author":[{"given":"Kouji","family":"Izumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Shigehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuo","family":"Ofude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yaegashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazufumi","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Nohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Kadono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Mizokami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,24]]},"reference":[{"key":"84054_CR1","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/1097-0142(19870915)60:6<1353::AID-CNCR2820600632>3.0.CO;2-5","volume":"60","author":"JA Zadra","year":"1987","unstructured":"Zadra, J. A. et al. Nonoperative urinary diversion for malignant ureteral obstruction. Cancer 60, 1353\u20131357 (1987).","journal-title":"Cancer"},{"key":"84054_CR2","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/BF02305670","volume":"3","author":"SM Donat","year":"1996","unstructured":"Donat, S. M. & Russo, P. Ureteral decompression in advanced nonurologic malignancies. Ann. Surg. Oncol. 3, 393\u2013399 (1996).","journal-title":"Ann. Surg. Oncol."},{"key":"84054_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1089\/end.2005.19.63","volume":"19","author":"BH Rosenberg","year":"2005","unstructured":"Rosenberg, B. H., Bianco, F. J. Jr., Wood, D. P. Jr. & Triest, J. A. Stent-change therapy in advanced malignancies with ureteral obstruction. J. Endourol. 19, 63\u201367. https:\/\/doi.org\/10.1089\/end.2005.19.63 (2005).","journal-title":"J. Endourol."},{"key":"84054_CR4","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/(SICI)1097-0142(19990215)85:4<998::AID-CNCR30>3.0.CO;2-F","volume":"85","author":"B Shekarriz","year":"1999","unstructured":"Shekarriz, B. et al. Outcome of palliative urinary diversion in the treatment of advanced malignancies. Cancer 85, 998\u20131003 (1999).","journal-title":"Cancer"},{"key":"84054_CR5","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.juro.2010.09.102","volume":"185","author":"K Izumi","year":"2011","unstructured":"Izumi, K., Mizokami, A., Maeda, Y., Koh, E. & Namiki, M. Current outcome of patients with ureteral stents for the management of malignant ureteral obstruction. J Urol 185, 556\u2013561. https:\/\/doi.org\/10.1016\/j.juro.2010.09.102 (2011).","journal-title":"J Urol"},{"key":"84054_CR6","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/j.1464-410X.2009.08492.x","volume":"104","author":"A Lienert","year":"2009","unstructured":"Lienert, A., Ing, A. & Mark, S. Prognostic factors in malignant ureteric obstruction. BJU Int. 104, 938\u2013941. https:\/\/doi.org\/10.1111\/j.1464-410X.2009.08492.x (2009).","journal-title":"BJU Int."},{"key":"84054_CR7","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.juro.2008.04.011","volume":"180","author":"J Ishioka","year":"2008","unstructured":"Ishioka, J., Kageyama, Y., Inoue, M., Higashi, Y. & Kihara, K. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases. J. Urol. 180, 618\u2013621. https:\/\/doi.org\/10.1016\/j.juro.2008.04.011 (2008) (discussion 621).","journal-title":"J. Urol."},{"key":"84054_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/bju.12963","volume":"117","author":"MD Cordeiro","year":"2016","unstructured":"Cordeiro, M. D. et al. A prognostic model for survival after palliative urinary diversion for malignant ureteric obstruction: a prospective study of 208 patients. BJU Int. 117, 266\u2013271. https:\/\/doi.org\/10.1111\/bju.12963 (2016).","journal-title":"BJU Int."},{"key":"84054_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-020-05413-0","author":"H Matsuura","year":"2020","unstructured":"Matsuura, H., Arase, S. & Hori, Y. Clinical outcomes and prognostic factors associated with internal ureteral stent placement for malignant extrinsic ureteral obstruction. Support Care Cancer https:\/\/doi.org\/10.1007\/s00520-020-05413-0 (2020).","journal-title":"Support Care Cancer"},{"key":"84054_CR10","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s10147-018-1348-6","volume":"24","author":"H Matsuura","year":"2019","unstructured":"Matsuura, H., Arase, S. & Hori, Y. Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure. Int. J. Clin. Oncol. 24, 306\u2013312. https:\/\/doi.org\/10.1007\/s10147-018-1348-6 (2019).","journal-title":"Int. J. Clin. Oncol."},{"key":"84054_CR11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1442-2042.2011.02731.x","volume":"18","author":"Y Kamiyama","year":"2011","unstructured":"Kamiyama, Y. et al. Stent failure in the management of malignant extrinsic ureteral obstruction: risk factors. Int. J. Urol. 18, 379\u2013382. https:\/\/doi.org\/10.1111\/j.1442-2042.2011.02731.x (2011).","journal-title":"Int. J. Urol."},{"key":"84054_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11934-018-0773-4","volume":"19","author":"JW Lucas","year":"2018","unstructured":"Lucas, J. W., Ghiraldi, E., Ellis, J. & Friedlander, J. I. Endoscopic management of ureteral strictures: an update. Curr. Urol. Rep. 19, 24. https:\/\/doi.org\/10.1007\/s11934-018-0773-4 (2018).","journal-title":"Curr. Urol. Rep."},{"key":"84054_CR13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.5527\/wjn.v5.i2.172","volume":"5","author":"L Hsu","year":"2016","unstructured":"Hsu, L. et al. Use of percutaneous nephrostomy and ureteral stenting in management of ureteral obstruction. World J. Nephrol. 5, 172\u2013181. https:\/\/doi.org\/10.5527\/wjn.v5.i2.172 (2016).","journal-title":"World J. Nephrol."},{"key":"84054_CR14","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jvir.2017.02.031","volume":"28","author":"JL McDevitt","year":"2017","unstructured":"McDevitt, J. L. et al. Long-term percutaneous nephrostomy management of malignant urinary obstruction: estimation of optimal exchange frequency and estimation of the financial impact of patient compliance. J. Vasc. Interv. Radiol. 28, 1036-1042 e1038. https:\/\/doi.org\/10.1016\/j.jvir.2017.02.031 (2017).","journal-title":"J. Vasc. Interv. Radiol."},{"key":"84054_CR15","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/iju.13500","volume":"25","author":"J Asakawa","year":"2018","unstructured":"Asakawa, J. et al. Outcomes of indwelling metallic stents for malignant extrinsic ureteral obstruction. Int. J. Urol. 25, 258\u2013262. https:\/\/doi.org\/10.1111\/iju.13500 (2018).","journal-title":"Int. J. Urol."},{"key":"84054_CR16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.clgc.2013.04.030","volume":"11","author":"T Azuma","year":"2013","unstructured":"Azuma, T., Nagase, Y. & Oshi, M. Prognostic marker for patients with malignant ureter obstruction. Clin. Genitourin. Cancer 11, 353\u2013356. https:\/\/doi.org\/10.1016\/j.clgc.2013.04.030 (2013).","journal-title":"Clin. Genitourin. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84054-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84054-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84054-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T04:18:39Z","timestamp":1670041119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84054-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,24]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["84054"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-84054-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,24]]},"assertion":[{"value":"21 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4455"}}